ARTICLE | Finance
Promoting PANAMs
Sage B round to fund clinical data for allosteric modulators in 3 CNS settings
October 28, 2013 7:00 AM UTC
Between a fresh $20 million series B round and a variety of non-dilutive funding sources, Sage Therapeutics Inc. now has enough money to get clinical data for three of its CNS programs.
Existing investors Arch Venture Partners and Third Rock Ventures participated in the financing...